|
|
Thread Tools | Display Modes |
#1
|
|||
|
|||
National Review blows its cork over NASA's Bolden
Brian Thorn wrote:
On Wed, 07 Jul 2010 20:28:12 -0800, Pat Flannery wrote: It's highly unlikely the ISS will ever repay even a small part of its development, construction, and resupply costs in any sort of a tangible economic way at any point in the future. If the Salmonella vaccine pans out, it might already have. Salmonellosis kills an estimated 3 million people a year, mostly in the third world (142,000 were sickened in the US last year and 30 died). http://dsc.discovery.com/news/2009/0...a-vaccine.html We have ten years or more of Space Station research ahead of us. Reports of ISS's failure to earn its keep are greatly exaggerated. Interesting had not heard about this. Thanks for sharing. I was aware there was a lot of research being done, I just had not been paying close attention to exactly what though. Brian -- Greg Moore Ask me about lily, an RPI based CMC. |
#2
|
|||
|
|||
National Review blows its cork over NASA's Bolden
On 7/9/2010 4:45 AM, Greg D. Moore (Strider) wrote:
If the Salmonella vaccine pans out, it might already have. Salmonellosis kills an estimated 3 million people a year, mostly in the third world (142,000 were sickened in the US last year and 30 died). http://dsc.discovery.com/news/2009/0...a-vaccine.html We have ten years or more of Space Station research ahead of us. Reports of ISS's failure to earn its keep are greatly exaggerated. Interesting had not heard about this. Thanks for sharing. I was aware there was a lot of research being done, I just had not been paying close attention to exactly what though. Although human testing of that vaccine was possibly going to start in 2010 according to the press releases, there has been no new info on it since last September. The company that did this research - Astrogenetix - now says they are working on a MRSA vaccine*, and you don't hear about the Salmonella cure anymo http://www.astrogenetix.com/news-and-events Read between the lines about what they are about: http://www.astrogenetix.com/about-us ....and what they are about is getting government funding to do experiments in space that make it look like worthwhile medical research is being done by NASA. They got started as a subsidiary of Astrotech Corporation, itself the new name for Spacehab Inc.: http://en.wikipedia.org/wiki/Astrotech_Corporation (That in turn being a new name for Johnson Engineering.) Nice work if you can get it, but I wouldn't expect to see much coming out of the company for all the taxpayer dollars that go into it. In interesting corporate news, one of their big boys just jumped ship on them: http://www.marke****ch.com/story/gen...ors-2010-06-17 * I expect the Common Cold vaccine to follow next year, followed by the vaccine for the Boogie-Woogie Flu in 2012, and the vaccine against death in 2013. :-D Pat |
#3
|
|||
|
|||
National Review blows its cork over NASA's Bolden
On 7/9/2010 10:51 AM, Pat Flannery wrote:
In interesting corporate news, one of their big boys just jumped ship on them: http://www.marke****ch.com/story/gen...ors-2010-06-17 The big boy in question: http://en.wikipedia.org/wiki/Lance_W._Lord Mighty impressive climb there; from second lieutenant in 1968 to four-star general in 2002, especially given that he never attended the Air Force Academy. And if that name rings a bell in regards to the last administration: http://www.nytimes.com/2005/05/18/business/18space.html 'The Air Force believes "we must establish and maintain space superiority," Gen. Lance Lord, who leads the Air Force Space Command, told Congress recently. "Simply put, it's the American way of fighting." Air Force doctrine defines space superiority as "freedom to attack as well as freedom from attack" in space.' Jeeze, I wish we had one of them Doomsday Machines! ;-) Pat |
#4
|
|||
|
|||
National Review blows its cork over NASA's Bolden
On Fri, 09 Jul 2010 10:51:33 -0800, Pat Flannery
wrote: Interesting had not heard about this. Thanks for sharing. I was aware there was a lot of research being done, I just had not been paying close attention to exactly what though. Although human testing of that vaccine was possibly going to start in 2010 according to the press releases, there has been no new info on it since last September. That's not too surprising. If testing was to begin in 2010, I wouldn't expect to hear results until at least 2011, maybe 2012. We usually see press releases from a company announcing product testing and the like, and then nothing, sometimes for years, while that testing progresses and goes to the FDA for approval. Brian |
#5
|
|||
|
|||
National Review blows its cork over NASA's Bolden
On 7/10/2010 8:44 AM, Brian Thorn wrote:
That's not too surprising. If testing was to begin in 2010, I wouldn't expect to hear results until at least 2011, maybe 2012. We usually see press releases from a company announcing product testing and the like, and then nothing, sometimes for years, while that testing progresses and goes to the FDA for approval. In this case though they put in for permission to do human testing last year...and you never heard if they got approval to do it. Which makes me suspect they never got the OK to do it, as if they had they would have announced it, because it certainly would have had a positive effect on their stock prices. Astrogenetix doesn't seem to be separately traded from its parent company Astrotech, but if you think this is going to be a big success, you may want to buy some Astrotech stock - which at the moment will set you back a whopping $1.33* per sha http://finance.yahoo.com/q/bc?s=ASTC...=on&z=m&q=l&c= This is a very small company BTW, having only 76 full-time employees. And that's the whole of Astrotech; not just the Astrogenetix subdivision. *In the last year it got down to $.98 at one point. Pat |
Thread Tools | |
Display Modes | |
|
|
Similar Threads | ||||
Thread | Thread Starter | Forum | Replies | Last Post |
National Review blows its cork over NASA's Bolden | Pat Flannery | Policy | 36 | July 12th 10 09:39 AM |
Bolden to review HLV study on Friday - Sidemount in doubt, In-line/SSME boost | Jeff Findley | Policy | 3 | January 19th 10 09:31 PM |
NASA's Ares I Rocket Passes Review To Reach Critical Milestone | [email protected] | Policy | 35 | April 8th 09 03:29 AM |
From the National Review Online... | Jim Davis | Policy | 15 | June 23rd 05 07:44 PM |
NASA's National Transonic Facility Turns 20 | [email protected] | News | 0 | December 5th 03 12:35 PM |